| 摘要 |
OF THE DISCLOSURE THE PRESENT INVENTION RELATES TO CERTAIN 3-PHERVI-PYRAZOLE DERIVATIVES OL'FORNLLILA (LA) AND PHARMACEUTICAL COMPOSITIONS THCREOL'THAI MODULAIE THE ACTIVITY OFTLIC 5-1 SEROTONIN RECEPTOR. IR4 R6 R8@ Y @X' N I R9 R3 R2 (LA) 5 COMPOUNDS AND PHAMNACEUTICAL COMPOSITIONS THEREOF ARE DIRECTED TO METHODS USEFUL IN TIRE TREATMENT OF PLATELET AGGREAGATION, CORONARY ARTERY DISEASE, MYOCARDIAL INFARCTION. TRANSIENT ISCHENLIC. ATTACK, ANGINA, STROKE, ATRIA] FIBRILLATION, RCDUCING THE RISK OF BLOOD CLOT FORMATION, ASTLINIA OR SYRILPLOINS THEREOF, AGITATION OR A SYMPLOM, BEHAVIORAL DISORDERS, DRUG INDUCED PSYCHOSIS, EXCITATIVE PSYCHOSIS, GILLES DE LA TOURCUE'S SVNDRONIC, MANIC DISORDER, ORGANIC OR NOS PSYCHOSIS, PSYCHOTIC DISORDER, PSYCHOSIS, ACULE 0 SCHIZOPHRENIA, CHRONIC SCHIZOPHRENIA, NOS SCHIZOPHRENIA AND RELATED DISORDERS, AND SLEEP DISORDERS, SLEEP DISORDERS, DIABETIC-RELATED DISORDERS, PROGRESSIVE MULLIFOCAL IEUKOENCEPHALOPATHY AND THE LIKE. THE PRESENT INVENTION ALSO RELATES TO THE METHODS FOR TIRE TREATMENT OI'5-11'1'21 SEYOTONIN RECEPTOR MEDIATED DISORDERS IN COMBINATION WITH OTHER PHARMACCUTICAL AGCNIS ADMINISTERED SEPARATELY OR TOGETHER. 5 |
